Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: a real-world retrospective study

Non ancora tradotto Non ancora tradotto
Autori
Categoria Primary study
GiornaleJ Crohn’s Colitis
Year 2020
Loading references information
Questo articolo non ha abstract
Epistemonikos ID: 0c1ff290c32af9ba47bc6c848cd6c9401db1523d
First added on: Dec 18, 2021